Valuation: BioGaia AB

Market Cap 11.43B 1.2B 1.04B 975M 888M 1.67B 115B 1.69B 4.48B 57.67B 4.52B 4.42B 192B P/E 2026 *
29.5x
P/E 2027 * 24.1x
Enterprise Value 10.76B 1.13B 979M 918M 836M 1.57B 108B 1.59B 4.22B 54.31B 4.26B 4.16B 181B EV / Sales 2026 *
6.45x
EV / Sales 2027 * 5.75x
Free-Float
80.82%
Yield 2026 *
2.61%
Yield 2027 * 2.83%
1 day+1.95%
1 week+2.40%
Current month-0.35%
1 month-7.69%
3 months-11.38%
6 months+12.06%
Current year+8.47%
1 week 111.1
Extreme 111.1
116
1 month 110.3
Extreme 110.3
124.9
Current year 97.5
Extreme 97.5
136.3
1 year 93.4
Extreme 93.4
136.3
3 years 91.45
Extreme 91.45
139.7
5 years 68.88
Extreme 68.88
139.7
10 years 48.6
Extreme 48.6
139.7
Manager TitleAgeSince
Chief Executive Officer 60 29/09/2023
Director of Finance/CFO 59 04/11/2019
Chief Operating Officer 49 31/12/2020
Director TitleAgeSince
Chairman 77 31/12/2002
Chairman 76 24/04/2018
Director/Board Member 46 31/12/2014
Date Insider Type Main position Quantity % Market Cap.
13/02/26 Buy

Director

582 0.0006%
30/12/25 Buy

General Counsel

390 0.0004%
05/12/25 Buy

Chief Financial Officer

2,000 0.0020%
Change 5-day change 1-year change 3-year change Capi.($)
+1.95%+2.40%+22.29%+6.96% 1.2B
+0.86%+0.27%+41.18%+1.70% 80.23B
-1.02%-0.51%-2.54%+28.91% 50.64B
+1.46%-4.31%+10.21%+164.55% 46.87B
-1.39%+1.82%-50.22%-50.44% 46.34B
-0.31%+1.13%+54.13%-19.89% 31B
+2.44%+8.46%+130.94%-38.94% 25.28B
+1.56%+0.35%+43.64%+89.97% 24.36B
+1.65%+0.53%-2.21%+190.26% 20.81B
+3.95%+1.64%+62.92%+120.52% 16.08B
Average +1.13%+0.45%+31.03%+49.36% 34.28B
Weighted average by Cap. +0.64%+0.53%+24.42%+39.29%

Financials

2026 *2027 *
Net sales 1.67B 176M 152M 142M 130M 244M 16.81B 247M 654M 8.42B 660M 646M 28.02B 1.88B 198M 171M 160M 146M 274M 18.9B 278M 735M 9.47B 742M 726M 31.49B
Net income 387M 40.76M 35.19M 33.01M 30.07M 56.54M 3.9B 57.32M 152M 1.95B 153M 150M 6.5B 474M 49.92M 43.1M 40.43M 36.83M 69.25M 4.77B 70.21M 186M 2.39B 187M 183M 7.96B
Net Debt -667M -70.25M -60.65M -56.9M -51.82M -97.45M -6.72B -98.8M -261M -3.37B -264M -258M -11.19B -646M -67.99M -58.69M -55.06M -50.15M -94.3M -6.5B -95.61M -253M -3.26B -255M -250M -10.83B
Logo BioGaia AB
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The Company operates worldwide.
Employees
251
Date Price Change Volume
17/08/26 SEK 115.20 +1.95% 223,064
14/08/26 SEK 113.00 -0.09% 226,655
13/08/26 SEK 113.10 +1.34% 120,219
12/08/26 SEK 111.60 -0.53% 64,559
11/08/26 SEK 112.20 -0.27% 60,608
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
113.00SEK
Average target price
152.50SEK
Spread / Average Target
+34.96%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIOG B Stock